Myocardial infarctions (MIs), commonly known as heart attacks, occur in more than 1 million people in the United States each year. Approximately 60% of MI sufferers survive, and require special care, as the condition may lead to disability and put the patient at an increased risk for co-morbid conditions. This authoritative text presents clear options for rehabilitation, drug therapy, and schedules for laboratory testing for surviving myocardial infarction patients, as well as pharmacologic treatment choices.